Table of Contents 1 Squamous Non-Small Cell Lung Cancer Therapeutics Market Overview 1.1 Squamous Non-Small Cell Lung Cancer Therapeutics Product Overview 1.2 Squamous Non-Small Cell Lung Cancer Therapeutics Market Segment by Type 1.2.1 BMS-906024 1.2.2 Buparlisib Hydrochloride 1.2.3 FP-1039 1.2.4 Ipilimumab 1.2.5 JNJ-42756493 1.2.6 Lenvatinib 1.2.7 Others 1.3 Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type 1.3.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales and Growth by Type 1.3.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales and Market Share by Type (2014-2019) 1.3.3 Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue and Market Share by Type (2014-2019) 1.3.4 Global Squamous Non-Small Cell Lung Cancer Therapeutics Price by Type (2014-2019) 2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Competition by Company 2.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales and Market Share by Company (2014-2019) 2.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue and Share by Company (2014-2019) 2.3 Global Squamous Non-Small Cell Lung Cancer Therapeutics Price by Company (2014-2019) 2.4 Global Top Players Squamous Non-Small Cell Lung Cancer Therapeutics Manufacturing Base Distribution, Sales Area, Product Types 2.5 Squamous Non-Small Cell Lung Cancer Therapeutics Market Competitive Situation and Trends 2.5.1 Squamous Non-Small Cell Lung Cancer Therapeutics Market Concentration Rate 2.5.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Share of Top 5 and Top 10 Players 2.5.3 Mergers & Acquisitions, Expansion 3 Squamous Non-Small Cell Lung Cancer Therapeutics Company Profiles and Sales Data 3.1 Ascenta Therapeutics, Inc. 3.1.1 Company Basic Information, Manufacturing Base and Competitors 3.1.2 Squamous Non-Small Cell Lung Cancer Therapeutics Product Category, Application and Specification 3.1.3 Ascenta Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin(2014-2019) 3.1.4 Main Business Overview 3.2 AstraZeneca Plc 3.2.1 Company Basic Information, Manufacturing Base and Competitors 3.2.2 Squamous Non-Small Cell Lung Cancer Therapeutics Product Category, Application and Specification 3.2.3 AstraZeneca Plc Squamous Non-Small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin(2014-2019) 3.2.4 Main Business Overview 3.3 AVEO Pharmaceuticals, Inc. 3.3.1 Company Basic Information, Manufacturing Base and Competitors 3.3.2 Squamous Non-Small Cell Lung Cancer Therapeutics Product Category, Application and Specification 3.3.3 AVEO Pharmaceuticals, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin(2014-2019) 3.3.4 Main Business Overview 3.4 Bayer AG 3.4.1 Company Basic Information, Manufacturing Base and Competitors 3.4.2 Squamous Non-Small Cell Lung Cancer Therapeutics Product Category, Application and Specification 3.4.3 Bayer AG Squamous Non-Small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin(2014-2019) 3.4.4 Main Business Overview 3.5 BIND Therapeutics, Inc. 3.5.1 Company Basic Information, Manufacturing Base and Competitors 3.5.2 Squamous Non-Small Cell Lung Cancer Therapeutics Product Category, Application and Specification 3.5.3 BIND Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin(2014-2019) 3.5.4 Main Business Overview 3.6 Boehringer Ingelheim GmbH 3.6.1 Company Basic Information, Manufacturing Base and Competitors 3.6.2 Squamous Non-Small Cell Lung Cancer Therapeutics Product Category, Application and Specification 3.6.3 Boehringer Ingelheim GmbH Squamous Non-Small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin(2014-2019) 3.6.4 Main Business Overview 3.7 Bristol-Myers Squibb Company 3.7.1 Company Basic Information, Manufacturing Base and Competitors 3.7.2 Squamous Non-Small Cell Lung Cancer Therapeutics Product Category, Application and Specification 3.7.3 Bristol-Myers Squibb Company Squamous Non-Small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin(2014-2019) 3.7.4 Main Business Overview 3.8 Eli Lilly and Company 3.8.1 Company Basic Information, Manufacturing Base and Competitors 3.8.2 Squamous Non-Small Cell Lung Cancer Therapeutics Product Category, Application and Specification 3.8.3 Eli Lilly and Company Squamous Non-Small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin(2014-2019) 3.8.4 Main Business Overview 3.9 F. Hoffmann-La Roche Ltd. 3.9.1 Company Basic Information, Manufacturing Base and Competitors 3.9.2 Squamous Non-Small Cell Lung Cancer Therapeutics Product Category, Application and Specification 3.9.3 F. Hoffmann-La Roche Ltd. Squamous Non-Small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin(2014-2019) 3.9.4 Main Business Overview 3.10 Five Prime Therapeutics, Inc. 3.10.1 Company Basic Information, Manufacturing Base and Competitors 3.10.2 Squamous Non-Small Cell Lung Cancer Therapeutics Product Category, Application and Specification 3.10.3 Five Prime Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin(2014-2019) 3.10.4 Main Business Overview 3.11 Genentech, Inc. 3.12 Incyte Corporation 3.13 Johnson & Johnson 3.14 MacroGenics, Inc. 3.15 Novartis AG 3.16 Oncogenex Pharmaceuticals, Inc. 3.17 PsiOxus Therapeutics Limited 4 Squamous Non-Small Cell Lung Cancer Therapeutics Market Status and Outlook by Regions 4.1 Global Market Status and Outlook by Regions 4.1.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size and CAGR by Regions 4.1.2 North America 4.1.3 Asia-Pacific 4.1.4 Europe 4.1.5 South America 4.1.6 Middle East and Africa 4.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales and Revenue by Regions 4.2.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales and Market Share by Regions (2014-2019) 4.2.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue and Market Share by Regions (2014-2019) 4.2.3 Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin (2014-2019) 4.3 North America Squamous Non-Small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin 4.3.1 United States 4.3.2 Canada 4.3.3 Mexico 4.4 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin 4.4.1 Germany 4.4.2 UK 4.4.3 France 4.4.4 Italy 4.4.5 Russia 4.4.6 Turkey 4.5 Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin 4.5.1 China 4.5.2 Japan 4.5.3 Korea 4.5.4 Southeast Asia 4.5.4.1 Indonesia 4.5.4.2 Thailand 4.5.4.3 Malaysia 4.5.4.4 Philippines 4.5.4.5 Vietnam 4.5.5 India 4.5.6 Australia 4.6 South America Squamous Non-Small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin 4.6.1 Brazil 4.7 Middle East and Africa Squamous Non-Small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin 4.7.1 Egypt 4.7.2 GCC Countries 5 Squamous Non-Small Cell Lung Cancer Therapeutics Application/End Users 5.1 Squamous Non-Small Cell Lung Cancer Therapeutics Segment by Application 5.1.1 Research Center 5.1.2 Hospital 5.1.3 Clinic 5.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Product Segment by Application 5.2.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales by Application 5.2.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales and Market Share by Application (2014-2019) 6 Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Forecast 6.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales, Revenue Forecast (2019-2025) 6.1.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales and Growth Rate Forecast (2019-2025) 6.1.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate Forecast (2019-2025) 6.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Forecast by Regions 6.2.1 North America Squamous Non-Small Cell Lung Cancer Therapeutics Sales and Revenue Forecast (2019-2025) 6.2.2 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Sales and Revenue Forecast (2019-2025) 6.2.3 Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Sales and Revenue Forecast (2019-2025) 6.2.3.1 China 6.2.3.2 Japan 6.2.3.3 Korea 6.2.3.4 Southeast Asia 6.2.3.5 India 6.2.3.6 Australia 6.2.4 South America Squamous Non-Small Cell Lung Cancer Therapeutics Sales and Revenue Forecast (2019-2025) 6.2.5 Middle East and Africa Squamous Non-Small Cell Lung Cancer Therapeutics Sales and Revenue Forecast (2019-2025) 6.2.5.1 Egypt 6.2.5.2 GCC Countries 6.3 Squamous Non-Small Cell Lung Cancer Therapeutics Forecast by Type 6.3.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales and Revenue Forecast by Type (2019-2025) 6.3.2 BMS-906024 Gowth Forecast 6.3.3 Buparlisib Hydrochloride Gowth Forecast 6.4 Squamous Non-Small Cell Lung Cancer Therapeutics Forecast by Application 6.4.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales Forecast by Application (2019-2025) 6.4.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Forecast in Research Center 6.4.3 Global Squamous Non-Small Cell Lung Cancer Therapeutics Forecast in Hospital 7 Squamous Non-Small Cell Lung Cancer Therapeutics Upstream Raw Materials 7.1 Squamous Non-Small Cell Lung Cancer Therapeutics Key Raw Materials 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price 7.1.3 Raw Materials Key Suppliers 7.2 Manufacturing Cost Structure 7.2.1 Raw Materials 7.2.2 Labor Cost 7.2.3 Manufacturing Expenses 7.3 Squamous Non-Small Cell Lung Cancer Therapeutics Industrial Chain Analysis 8 Marketing Strategy Analysis, Distributors 8.1 Marketing Channel 8.1.1 Direct Marketing 8.1.2 Indirect Marketing 8.1.3 Marketing Channel Development Trend 8.2 Distributors 8.3 Downstream Customers 9 Research Findings and Conclusion Appendix Methodology/Research Approach Research Programs/Design Market Size Estimation Market Breakdown and Data Triangulation Data Source Secondary Sources Primary Sources Disclaimer

List of Tables and Figures Figure Squamous Non-Small Cell Lung Cancer Therapeutics Product Picture Figure Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD) Status and Outlook (2014-2025) Figure Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) Status and Outlook (2014-2025) Figure Product Picture of BMS-906024 Table Major Players of BMS-906024 Figure Global BMS-906024 Sales (K Pcs) and Growth Rate (%)(2014-2018) Figure Product Picture of Buparlisib Hydrochloride Table Major Players of Buparlisib Hydrochloride Figure Global Buparlisib Hydrochloride Sales (K Pcs) and Growth Rate (%)(2014-2019) Figure Product Picture of FP-1039 Table Major Players of FP-1039 Figure Global FP-1039 Sales (K Pcs) and Growth Rate (%)(2014-2019) Figure Product Picture of Ipilimumab Table Major Players of Ipilimumab Figure Global Ipilimumab Sales (K Pcs) and Growth Rate (%)(2014-2019) Figure Product Picture of JNJ-42756493 Table Major Players of JNJ-42756493 Figure Global JNJ-42756493 Sales (K Pcs) and Growth Rate (%)(2014-2019) Figure Product Picture of Lenvatinib Table Major Players of Lenvatinib Figure Global Lenvatinib Sales (K Pcs) and Growth Rate (%)(2014-2019) Figure Product Picture of Others Table Major Players of Others Figure Global Others Sales (K Pcs) and Growth Rate (%)(2014-2019) Table Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) and Growth Rate (%) Comparison by Type Table Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) by Type (2014-2019) Table Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales Share (%) by Type (2014-2019) Figure Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales Market Share (%) by Type (2014-2019) Figure Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales Market Share (%) by Type in 2018 Table Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD) by Type (2014-2019) Table Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Share (%) by Type (2014-2019) Figure Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Share (%) by Type (2014-2019) Figure 2018 Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Market Share (%) by Type Table Global Squamous Non-Small Cell Lung Cancer Therapeutics Price (USD/Pcs) by Type (2014-2019) Table Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) by Company (2014-2019) Table Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales Share (%) by Company (2014-2019) Figure Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales Share (%) by Company in 2018 Table Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD) by Company (2014-2019) Table Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Share (%) by Company (2014-2019) Figure Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Share (%) by Company in 2018 Table Global Market Squamous Non-Small Cell Lung Cancer Therapeutics Average Price (USD/Pcs) by Company (2014-2019) Table Global Squamous Non-Small Cell Lung Cancer Therapeutics Top Players Manufacturing Base Distribution and Sales Area Table Global Squamous Non-Small Cell Lung Cancer Therapeutics Top Players Product Category Figure Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Share (%) of Top 5 Players Figure Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Share (%) of Top 10 Players Table Ascenta Therapeutics, Inc. Basic Information List Table Ascenta Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Product Category, Application and Specification Table Ascenta Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2014-2019) Figure Ascenta Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Sales Growth Rate (2014-2019) Figure Ascenta Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Sales Global Market Share (%)(2014-2019) Table AstraZeneca Plc Basic Information List Figure AstraZeneca Plc Squamous Non-Small Cell Lung Cancer Therapeutics Product Category, Application and Specification Table AstraZeneca Plc Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2014-2019) Figure AstraZeneca Plc Squamous Non-Small Cell Lung Cancer Therapeutics Sales Growth Rate (2014-2019) Figure AstraZeneca Plc Squamous Non-Small Cell Lung Cancer Therapeutics Sales Global Market Share (%)(2014-2019) Table AVEO Pharmaceuticals, Inc. Basic Information List Figure AVEO Pharmaceuticals, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Product Category, Application and Specification Table AVEO Pharmaceuticals, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2014-2019) Figure AVEO Pharmaceuticals, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Sales Growth Rate (2014-2019) Figure AVEO Pharmaceuticals, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Sales Global Market Share (%)(2014-2019) Table Bayer AG Basic Information List Figure Bayer AG Squamous Non-Small Cell Lung Cancer Therapeutics Product Category, Application and Specification Table Bayer AG Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2014-2019) Figure Bayer AG Squamous Non-Small Cell Lung Cancer Therapeutics Sales Growth Rate (2014-2019) Figure Bayer AG Squamous Non-Small Cell Lung Cancer Therapeutics Sales Global Market Share (%)(2014-2019) Table BIND Therapeutics, Inc. Basic Information List Figure BIND Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Product Category, Application and Specification Table BIND Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2014-2019) Figure BIND Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Sales Growth Rate (2014-2019) Figure BIND Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Sales Global Market Share (%)(2014-2019) Table Boehringer Ingelheim GmbH Basic Information List Figure Boehringer Ingelheim GmbH Squamous Non-Small Cell Lung Cancer Therapeutics Product Category, Application and Specification Table Boehringer Ingelheim GmbH Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2014-2019) Figure Boehringer Ingelheim GmbH Squamous Non-Small Cell Lung Cancer Therapeutics Sales Growth Rate (2014-2019) Figure Boehringer Ingelheim GmbH Squamous Non-Small Cell Lung Cancer Therapeutics Sales Global Market Share (%)(2014-2019) Table Bristol-Myers Squibb Company Basic Information List Figure Bristol-Myers Squibb Company Squamous Non-Small Cell Lung Cancer Therapeutics Product Category, Application and Specification Table Bristol-Myers Squibb Company Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2014-2019) Figure Bristol-Myers Squibb Company Squamous Non-Small Cell Lung Cancer Therapeutics Sales Growth Rate (2014-2019) Figure Bristol-Myers Squibb Company Squamous Non-Small Cell Lung Cancer Therapeutics Sales Global Market Share (%)(2014-2019) Table Eli Lilly and Company Basic Information List Figure Eli Lilly and Company Squamous Non-Small Cell Lung Cancer Therapeutics Product Category, Application and Specification Table Eli Lilly and Company Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2014-2019) Figure Eli Lilly and Company Squamous Non-Small Cell Lung Cancer Therapeutics Sales Growth Rate (2014-2019) Figure Eli Lilly and Company Squamous Non-Small Cell Lung Cancer Therapeutics Sales Global Market Share (%)(2014-2019) Table F. Hoffmann-La Roche Ltd. Basic Information List Figure F. Hoffmann-La Roche Ltd. Squamous Non-Small Cell Lung Cancer Therapeutics Product Category, Application and Specification Table F. Hoffmann-La Roche Ltd. Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2014-2019) Figure F. Hoffmann-La Roche Ltd. Squamous Non-Small Cell Lung Cancer Therapeutics Sales Growth Rate (2014-2019) Figure F. Hoffmann-La Roche Ltd. Squamous Non-Small Cell Lung Cancer Therapeutics Sales Global Market Share (%)(2014-2019) Table Five Prime Therapeutics, Inc. Basic Information List Figure Five Prime Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Product Category, Application and Specification Table Five Prime Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2014-2019) Figure Five Prime Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Sales Growth Rate (2014-2019) Figure Five Prime Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Sales Global Market Share (%)(2014-2019) Table Genentech, Inc. Basic Information List Table Incyte Corporation Basic Information List Table Johnson & Johnson Basic Information List Table MacroGenics, Inc. Basic Information List Table Novartis AG Basic Information List Table Oncogenex Pharmaceuticals, Inc. Basic Information List Table PsiOxus Therapeutics Limited Basic Information List Table Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Comparison by Regions (2014-2025) Figure North America Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD) and Growth Rate (%)(2014-2025) Figure Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD) and Growth Rate (%)(2014-2025) Figure Europe Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD) and Growth Rate (%)(2014-2025) Figure South America Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD) and Growth Rate (%)(2014-2025) Figure Middle East and Africa Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD) and Growth Rate (%)(2014-2025) Table Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) by Regions (2014-2019) Table Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales Market Share (%) by Regions (2014-2019) Figure Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales Market Share (%) by Regions (2014-2019) Figure 2018 Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales Market Share (%) by Regions Table Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD) by Regions (2014-2019) Table Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Market Share (%) by Regions (2014-2019) Figure Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Market Share (%) by Regions (2014-2019) Figure 2018 Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Market Share (%) by Regions Table Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2014-2019) Figure North America Squamous Non-Small Cell Lung Cancer Therapeutics Sales Growth Rate Table North America Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2014-2019) Figure United States Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs)(2014-2019) Figure United States Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD)(2014-2019) Figure Canada Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs)(2014-2019) Figure Canada Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD)(2014-2019) Figure Mexico Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs)(2014-2019) Figure Mexico Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD)(2014-2019) Figure Europe Squamous Non-Small Cell Lung Cancer Therapeutics Sales Growth Rate Table Europe Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2014-2019) Figure Germany Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs)(2014-2019) Figure Germany Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD) (2014-2019) Figure UK Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs)(2014-2019) Figure UK Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD)(2014-2019) Figure France Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs)(2014-2019) Figure France Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD)(2014-2019) Figure Italy Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs)(2014-2019) Figure Italy Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD)(2014-2019) Figure Russia Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs)(2014-2019) Figure Russia Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD)(2014-2019) Figure Turkey Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs)(2014-2019) Figure Turkey Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD)(2014-2019) Figure Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Sales Growth Rate Table Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2014-2019) Figure China Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs)(2014-2019) Figure China Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD)(2014-2019) Figure Japan Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs)(2014-2019) Figure Japan Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD)(2014-2019) Figure Korea Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs)(2014-2019) Figure Korea Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD)(2014-2019) Figure Southeast Asia Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs)(2014-2019) Figure Southeast Asia Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD)(2014-2019) Figure Indonesia Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs)(2014-2019) Figure Indonesia Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD)(2014-2019) Figure Thailand Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs)(2014-2019) Figure Thailand Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD)(2014-2019) Figure Malaysia Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs)(2014-2019) Figure Malaysia Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD)(2014-2019) Figure Philippines Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs)(2014-2019) Figure Philippines Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD)(2014-2019) Figure Vietnam Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs)(2014-2019) Figure Vietnam Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD)(2014-2019) Figure India Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs)(2014-2019) Figure India Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD)(2014-2019) Figure Australia Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs)(2014-2019) Figure Australia Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD)(2014-2019) Figure South America Squamous Non-Small Cell Lung Cancer Therapeutics Sales Growth Rate Table South America Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2014-2019) Figure Brazil Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs)(2014-2019) Figure Brazil Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD)(2014-2019) Figure Middle East and Africa Squamous Non-Small Cell Lung Cancer Therapeutics Sales Growth Rate Table Middle East and Africa Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2014-2019) Figure North Africa Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs)(2014-2019) Figure North Africa Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD)(2014-2019) Figure GCC Countries Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs)(2014-2019) Figure GCC Countries Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD)(2014-2019) Figure Research Center Examples Figure Hospital Examples Figure Clinic Examples Table Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) Comparison by Application (2014-2025) Table Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) by Application (2014-2019) Table Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales Share (%) by Application (2014-2019) Figure Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales Market Share (%) by Application (2014-2019) Figure Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales Market Share (%) by Application in 2018 Figure Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) and Growth Rate (%) Forecast (2019-2025) Figure Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD) and Growth Rate (%) Forecast (2019-2025) Table Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) Forecast by Regions (2019-2025) Figure Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales Market Share (%) Forecast by Regions (2019-2025) Figure North America Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) and Growth Rate (%) Forecast (2019-2025) Figure North America Squamous Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (%) Forecast (2019-2025) Figure Europe Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) and Growth Rate (%) Forecast (2019-2025) Figure Europe Squamous Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (%) Forecast (2019-2025) Figure Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) and Growth Rate (%) Forecast (2019-2025) Figure Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (%) Forecast (2019-2025) Figure China Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) and Growth Rate (%) Forecast (2019-2025) Figure China Squamous Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (%) Forecast (2019-2025) Figure Japan Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) and Growth Rate (%) Forecast (2019-2025) Figure Japan Squamous Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (%) Forecast (2019-2025) Figure Korea Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) and Growth Rate (%) Forecast (2019-2025) Figure Korea Squamous Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (%) Forecast (2019-2025) Figure Southeast Asia Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) and Growth Rate (%) Forecast (2019-2025) Figure Southeast Asia Squamous Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (%) Forecast (2019-2025) Figure India Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) and Growth Rate (%) Forecast (2019-2025) Figure India Squamous Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (%) Forecast (2019-2025) Figure Australia Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) and Growth Rate (%) Forecast (2019-2025) Figure Australia Squamous Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (%) Forecast (2019-2025) Figure South America Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) and Growth Rate (%) Forecast (2019-2025) Figure South America Squamous Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (%) Forecast (2019-2025) Figure Middle East and Africa Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) and Growth Rate (%) Forecast (2019-2025) Figure Middle East and Africa Squamous Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (%) Forecast (2019-2025) Figure North Africa Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) and Growth Rate (%) Forecast (2019-2025) Figure North Africa Squamous Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (%) Forecast (2019-2025) Figure GCC Countries Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) and Growth Rate (%) Forecast (2019-2025) Figure GCC Countries Squamous Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (%) Forecast (2019-2025) Table Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales (Million USD) Forecast by Type (2019-2025) Figure Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales Market Share (%) Forecast by Type (2019-2025) Table Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD) Forecast by Type (2019-2025) Figure Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Market Share (%) Forecast by Type (2019-2025) Figure BMS-906024 Sales Growth Forecast Figure Buparlisib Hydrochloride Sales Growth Forecast Table Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) Forecast by Application (2019-2025) Figure Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales Forecast by Application (2019-2025) Figure Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) Forecast in Research Center Figure Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Pcs) Forecast in Hospital Table Key Raw Materials Lists Figure Key Raw Materials Price Table Raw Materials Key Suppliers Lists Figure Squamous Non-Small Cell Lung Cancer Therapeutics Manufacturing Cost Structure Figure Squamous Non-Small Cell Lung Cancer Therapeutics Industrial Chain Analysis Table Distributors List Table Squamous Non-Small Cell Lung Cancer Therapeutics Downstream Customers

Ascenta Therapeutics, Inc. AstraZeneca Plc AVEO Pharmaceuticals, Inc. Bayer AG BIND Therapeutics, Inc. Boehringer Ingelheim GmbH Bristol-Myers Squibb Company Eli Lilly and Company F. Hoffmann-La Roche Ltd. Five Prime Therapeutics, Inc. Genentech, Inc. Incyte Corporation Johnson & Johnson MacroGenics, Inc. Novartis AG Oncogenex Pharmaceuticals, Inc. PsiOxus Therapeutics Limited